BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31349950)

  • 1. Soluble ICAM 1 and VCAM 1 Blood Levels Alert on Subclinical Atherosclerosis in Non Smokers with Asymptomatic Metabolic Syndrome.
    Varona JF; Ortiz-Regalón R; Sánchez-Vera I; López-Melgar B; García-Durango C; Castellano Vázquez JM; Solís J; Fernández-Friera L; Vidal-Vanaclocha F
    Arch Med Res; 2019 Feb; 50(2):20-28. PubMed ID: 31349950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk.
    Kressel G; Trunz B; Bub A; Hülsmann O; Wolters M; Lichtinghagen R; Stichtenoth DO; Hahn A
    Atherosclerosis; 2009 Jan; 202(1):263-71. PubMed ID: 18501910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble intracellular adhesion molecule-1 and omentin-1 as potential biomarkers of subclinical atherosclerosis in hemodialysis patients.
    Kocijancic M; Cubranic Z; Vujicic B; Racki S; Dvornik S; Zaputovic L
    Int Urol Nephrol; 2016 Jul; 48(7):1145-54. PubMed ID: 27023478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome.
    Liu R; Wang X; Bu P
    Diabetes Res Clin Pract; 2011 Jul; 93(1):21-5. PubMed ID: 21497934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum leptin levels are associated with metabolic syndrome and carotid intima media thickness in premenopausal systemic lupus erythematosus patients without clinical atherosclerotic vascular events.
    Demir S; Erten G; Artım-Esen B; Şahinkaya Y; Pehlivan Ö; Alpay-Kanıtez N; Deniz G; Inanç M
    Lupus; 2018 Aug; 27(9):1509-1516. PubMed ID: 29954279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound.
    Schiopu E; Au KM; McMahon MA; Kaplan MJ; Divekar A; Singh RR; Furst DE; Clements PJ; Ragvendra N; Zhao W; Maranian P; Khanna D
    Rheumatology (Oxford); 2014 Apr; 53(4):704-13. PubMed ID: 24357811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis.
    De Caterina R; Basta G; Lazzerini G; Dell'Omo G; Petrucci R; Morale M; Carmassi F; Pedrinelli R
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2646-54. PubMed ID: 9409238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of endothelial and oxidative stress with metabolic syndrome and subclinical atherosclerosis: multi-ethnic study of atherosclerosis.
    Vaidya D; Szklo M; Cushman M; Holvoet P; Polak J; Bahrami H; Jenny NS; Ouyang P
    Eur J Clin Nutr; 2011 Jul; 65(7):818-25. PubMed ID: 21505504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating ICAM-1 (intercellular cell-adhesion molecule 1) is associated with early stages of atherosclerosis development and with inflammatory cytokines in healthy 58-year-old men: the Atherosclerosis and Insulin Resistance (AIR) study.
    Hulthe J; Wikstrand J; Mattsson-Hultén L; Fagerberg B
    Clin Sci (Lond); 2002 Aug; 103(2):123-9. PubMed ID: 12149102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of subclinical atherosclerosis in subjects with rheumatoid arthritis and the metabolic syndrome.
    Burggraaf B; van Breukelen-van der Stoep DF; de Vries MA; Klop B; van Zeben J; van de Geijn GM; van der Meulen N; Birnie E; Prinzen L; Castro Cabezas M
    Atherosclerosis; 2018 Apr; 271():84-91. PubMed ID: 29482038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians.
    Thakur ML; Sharma S; Kumar A; Bhatt SP; Luthra K; Guleria R; Pandey RM; Vikram NK
    Atherosclerosis; 2012 Aug; 223(2):507-11. PubMed ID: 22748277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating soluble intercellular adhesion molecule 1 and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults Study.
    Gross MD; Bielinski SJ; Suarez-Lopez JR; Reiner AP; Bailey K; Thyagarajan B; Carr JJ; Duprez DA; Jacobs DR
    Clin Chem; 2012 Feb; 58(2):411-20. PubMed ID: 22179741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Type II Secretory Phospholipase A2 Increases the Risk of Early Atherosclerosis in Patients with Newly Diagnosed Metabolic Syndrome.
    Sun CQ; Zhong CY; Sun WW; Xiao H; Zhu P; Lin YZ; Zhang CL; Gao H; Song ZY
    Sci Rep; 2016 Dec; 6():34929. PubMed ID: 27941821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of subclinical atherosclerosis in schoolchildren with obesity and metabolic syndrome.
    Al-Shorman A; Al-Domi H; Faqih A
    Swiss Med Wkly; 2017 May; 147():w14446. PubMed ID: 33378543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of novel adipokines, RBP4 and omentin-1, with carotid atherosclerosis severity and vulnerability.
    Kadoglou NP; Lambadiari V; Gastounioti A; Gkekas C; Giannakopoulos TG; Koulia K; Maratou E; Alepaki M; Kakisis J; Karakitsos P; Nikita KS; Dimitriadis G; Liapis CD
    Atherosclerosis; 2014 Aug; 235(2):606-12. PubMed ID: 24956535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of subclinical atherosclerosis in schoolchildren with obesity and metabolic syndrome.
    Al-Shorman A; Al-Domi H; Faqih A
    Swiss Med Wkly; 2017; 147():w14446. PubMed ID: 28634974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between markers of endothelial dysfunction and inflammation and subclinical atherosclerosis in HIV-infected male patients below 55 years of age.
    Pirš M; Jug B; Eržen B; Šabović M; Karner P; Poljak M; Tomažič J
    Acta Dermatovenerol Alp Pannonica Adriat; 2014; 23(3):49-52. PubMed ID: 25242160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of low serum Meteorin like (Metrnl) concentrations with worsening of glucose tolerance, impaired endothelial function and atherosclerosis.
    El-Ashmawy HM; Selim FO; Hosny TAM; Almassry HN
    Diabetes Res Clin Pract; 2019 Apr; 150():57-63. PubMed ID: 30825562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Association Between Endothelial Dysfunction, Inflammation, and Clotting Biomarkers With Subclinical Atherosclerosis in Type 1 Diabetes: An Evaluation of the DCCT/EDIC Cohort.
    Hunt KJ; Baker NL; Cleary PA; Klein R; Virella G; Lopes-Virella MF;
    Diabetes Care; 2015 Jul; 38(7):1281-9. PubMed ID: 25852210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.